HIV treatment: latest news

HIV treatment resources

HIV treatment features

HIV treatment in your own words

HIV treatment news from aidsmap

More news

HIV treatment news selected from other sources

  • Sources of Information for Self-care Among Patients Living with HIV

    The purpose of this study was “to identify the helpful information sources for self-care strategies, including Common sense/Self-experience, Healthcare professional, Internet, Literature, Multiple, Social Support and TV ads.

    20 February 2018 | MD Magazine
  • What does an HIV cure mean to you?

    We did a study to better understand the meanings of HIV cure among people living with HIV. This is critical to reconcile what would be clinically feasible with what would be meaningful for people living with HIV.

    06 February 2018 | Positively Aware
  • Immediate HIV Treatment Has Little Impact on Risk of Future Drug Resistance

    Starting antiretroviral therapy (ART) immediately rather waiting until a person's CD4 count falls below 500 cells/µL has almost no impact on the person's risk of developing antiretroviral resistance over the next seven years, according to a study published online in the journal AIDS. In this 51,000-person analysis, the impact of immediate ART on acquired drug resistance disappeared almost completely among people starting treatment in 2005 or later.

    07 January 2018 | The Body Pro
  • NHS England have announced funding for immediate antiretroviral treatment for HIV patients

    NHS England has announced that it has agreed that HIV antiretroviral medication will be provided to patients immediately once someone is diagnosed.

    19 December 2017 | Gay Times
  • Could we safely reduce the frequency of treatments for HIV-positive people?

    Most HIV-positive people in France under treatment take a daily dose of antiviral drugs for life. However, a major trial is currently underway that may confirm that patients could omit several days of treatment a week without risk to their health.

    08 December 2017 | The Conversation
  • Top 10 HIV Clinical Developments of 2017

    By David Alain Wohl, M.D., professor of medicine in the Division of Infectious Diseases at the University of North Carolina (UNC).

    19 November 2017 | The Body Pro
  • ViiV Survey Reveals Nuances of Living With HIV

    Respondents reported on their feelings about antiretrovirals, their relationships with their clinicians and dealing with stigma.

    30 October 2017 | Poz
  • Viral Rebound Unlikely for Many on ART

    British investigators have determined that a substantial proportion of people with HIV who are taking antiretroviral therapy (ART) will not experience viral rebound during their lifetime.

    14 July 2017 | Infectious Disease Special Edition
  • HIV: A therapeutic advance for resource-limited settings

    ANRS 12286 MOBIDIP, a clinical trial running in parallel in three countries in sub-Saharan Africa, shows that dual therapy with lamivudine and a boosted protease inhibitor is effective as second-line treatment in patients infected by HIV with multiple mutations. Such treatment deescalation will reduce costs, side effects, and the need for virological monitoring of patients. The results of this study are published in The Lancet HIV.

    31 May 2017 | Eurekalert Inf Dis
  • The Truth About HIV

    Dr Chris van Tulleken explores the latest science around HIV, meeting health professionals, scientists, and individuals affected by it in the UK and South Africa.

    26 May 2017 | BBC iPlayer (UK only, available until 24 June)
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.